search

Skip to results

Modify your search

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Availability

All content I have access to

Open Access

NARROW

Format

Facet list

Journal Article (1)

Type

Facet list

Review Article (1)

Section

Find a Section

The list will update as you type

Facet list

Review (1)
Special Issue: Emerging Schizophrenia Treatment (1)

Publication date

Date Range

Published
Updated

Date range

Single date

From Select month

To Select month

Publication date

1-1 of 1

Authors: Ken Kramer

Save search

Follow your search

Access your saved searches in your account

Name your search

Follow this search

Would you like to receive an alert when new items match your search?

Save search

Sort by

Sort Order Select

Journal Article

From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M₁/M₄ muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials

PDF

Jonathan M Meyer and others

International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf015, https://doi.org/10.1093/ijnp/pyaf015

Published: 08 March 2025

Email alerts

New journal issues

New journal articles

Perform this search in

Journals Journals

Books Books

Oxford Academic Oxford Academic

Modify your search

Publication date

From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials

Email alerts

This Feature Is Available To Subscribers Only

From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M₁/M₄ muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials